Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Carboplatin/therapeutic use"'
Autor:
Carsten Friedrich, André O. von Bueren, Christine Haberler, Brigitte Bison, B-Ole Juhnke, Beate Timmermann, Marcel Kool, Robert Kwiecien, Nicolas U. Gerber, Torsten Pietsch, Stefan M. Pfister, Marco Gessi, Katja von Hoff, Monika Warmuth-Metz, Martin Mynarek, Rolf-Dieter Kortmann, Ulrich Schüller, Stefan Rutkowski, Claudia Spix
Publikováno v:
Neuro Oncol
Juhnke, B-O, Gessi, M, Gerber, N U, Friedrich, C, Mynarek, M, von Bueren, A O, Haberler, C, Schüller, U, Kortmann, R-D, Timmermann, B, Bison, B, Warmuth-Metz, M, Kwiecien, R, Pfister, S M, Spix, C, Pietsch, T, Kool, M, Rutkowski, S & von Hoff, K 2022, ' Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial ', Neuro-Oncology, vol. 24, no. 1, pp. 127-137 . https://doi.org/10.1093/neuonc/noab100
Neuro-oncology (2021)
Juhnke, B-O, Gessi, M, Gerber, N U, Friedrich, C, Mynarek, M, von Bueren, A O, Haberler, C, Schüller, U, Kortmann, R-D, Timmermann, B, Bison, B, Warmuth-Metz, M, Kwiecien, R, Pfister, S M, Spix, C, Pietsch, T, Kool, M, Rutkowski, S & von Hoff, K 2022, ' Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial ', Neuro-Oncology, vol. 24, no. 1, pp. 127-137 . https://doi.org/10.1093/neuonc/noab100
Neuro-oncology (2021)
Background Embryonal tumors with multilayered rosettes (ETMR) are highly aggressive tumors occurring in early childhood. Published clinical data refer to retrospective, heterogeneously treated cohorts. Here, we describe the outcome of patients treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0967be33affa38e8991c236708f92a00
https://europepmc.org/articles/PMC8730753/
https://europepmc.org/articles/PMC8730753/
Publikováno v:
Berg, T, Nøttrup, T J, Peen, U B S & Roed, H 2020, ' Treatment and outcomes of a Danish ovarian cancer population ', Danish Medical Journal, vol. 67, no. 1, A06190346 .
INTRODUCTION: Ovarian cancer has the highest mortality rate among gynaecological cancers and is the tenth most frequent cancer among women. 80% of patients with advanced stage disease will experience a progression either during or after treatment.MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2751::4b8f3dd6c1fcfec6d7b0e1d0f1256c66
https://curis.ku.dk/portal/da/publications/treatment-and-outcomes-of-a-danish-ovarian-cancer-population(acb725ea-8f8e-4a0a-a96c-1885a33e95a9).html
https://curis.ku.dk/portal/da/publications/treatment-and-outcomes-of-a-danish-ovarian-cancer-population(acb725ea-8f8e-4a0a-a96c-1885a33e95a9).html
Autor:
Paul A. Cohen, Aime Powell, Steffen Böhm, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Bulsara, Stefanie Avril, Eleanor C. Brockbank, Tjalling Bosse, Gustavo Rubino de Azevedo Focchi, Raji Ganesan, Rosalind M. Glasspool, Brooke E. Howitt, Hyun-Soo Kim, Jung-Yun Lee, Nhu D. Le, Michelle Lockley, Ranjit Manchanda, Trupti Mandalia, W. Glenn McCluggage, Iain McNeish, Divya Midha, Radhika Srinivasan, Yun Yi Tan, Rachael van der Griend, Mayu Yunokawa, Gian F. Zannoni, Naveena Singh, Simi Aggarwal, Holger Bronger, Elizabeth B. Brown, Martin Buck, Syed A. Bukhari, Edwina Coghlan, Nichola Cope, Michelle Samora de Almeida, Cornelius D. De Kroon, Andrew Dean, Michael-John Devlin, Helena M. Ditzel, Enken Drecoll, Takahiro Ebata, Anna Fagotti, Asma Faruqi, Laura Feeney, Kavita Gupta, Ian Harley, Frediano Inzani, Arjun R. Jeyarajah, M.H. Eleanor Koay, Judith R. Kroep, Yee Leung, Alice R. Loft, Daniel MaGee, Sarah McKenna, David Millan, Joanne Millar, Rowan Miller, Ganendra R. Mohan, Sohail Mughal, Asima Mukhopadhyay, Sergio Mancini Nicolau, James Nevin, Abigail S. Oakley, Mary Quigley, Bhavana Rai, Arvind Rajwanshi, Stuart G. Salfinger, Giovanni Scambia, Kate Scatchard, Barbara Schmalfeldt, Bryony Simcock, Priya Singh, Kyle C. Strickland, Vainta Suri, Sheeba Syed, Peter Sykes, Kenji Tamura, Adeline Tan, Jason Tan, Emily Thompson, Anna V. Tinker, Georgia Trevisan, Maria Gabriela Baumgarten Kuster Uyeda, Michelle M. Vaughan, Wilko Weichert, Anthony Williams, Sarah Williams, Hiroshi Yoshida, Pier Carlo Zorzato
Publikováno v:
Cohen, P A, Powell, A, Böhm, S, Gilks, C B, Stewart, C J R, Meniawy, T M, Bulsara, M, Avril, S, Brockbank, E C, Bosse, T, de Azevedo Focchi, G R, Ganesan, R, Glasspool, R M, Howitt, B E, Kim, H S, Lee, J Y, Le, N D, Lockley, M, Manchanda, R, Mandalia, T, McCluggage, W G, McNeish, I, Midha, D, Srinivasan, R, Tan, Y Y, van der Griend, R, Yunokawa, M, Zannoni, G F, The HGSC CRS Collaborative Network (Supplementary 1) & Møgelbjerg Ditzel, H 2019, ' Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma : A systematic review and meta-analysis of individual patient data ', Gynecologic Oncology, vol. 154, no. 2, pp. 441-448 . https://doi.org/10.1016/j.ygyno.2019.04.679
Gynecologic Oncology, 154(2), 441-448. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 154(2), 441-448. ACADEMIC PRESS INC ELSEVIER SCIENCE
Objective. There is a need to develop and validate biomarkers for treatment response and survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response score (CRS) stratifies patients into complete/near-complete (CRS3), partia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a0a3d918f62859dca88e8d5a6e292c
https://findresearcher.sdu.dk:8443/ws/files/174798070/PIIS0090825819311813.pdf
https://findresearcher.sdu.dk:8443/ws/files/174798070/PIIS0090825819311813.pdf
Autor:
Pablo Maroto, Torgrim Tandstad, Paul Hutton, Aude Flechon, Breda Škrbinc, Dirk Klingbiel, Matthew Wheater, Caroline Chau, Olof Ståhl, Jörg Beyer, Silke Gillessen, Jonathan Shamash, Brigitte Laguerre, Edurne Arriola, Klaus Peter Dieckmann, Stefanie Fischer, Anja Lorch, Kalena Marti, Umberto Basso, Emilio Porfiri, Gabriella Cohn-Cedermark, Jorge Aparicio
Publikováno v:
Fischer, S, Tandstad, T, Wheater, M, Porfiri, E, Fléchon, A, Aparicio, J, Klingbiel, D, Skrbinc, B, Basso, U, Shamash, J, Lorch, A, Dieckmann, K-P, Cohn-Cedermark, G, Ståhl, O, Chau, C, Arriola, E, Marti, K, Hutton, P, Laguerre, B, Maroto, P, Beyer, J & Gillessen, S 2017, ' Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 35, no. 2, pp. 194-200 . https://doi.org/10.1200/JCO.2016.69.0958
JOURNAL OF CLINICAL ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
JOURNAL OF CLINICAL ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Purpose Adjuvant carboplatin is one of three management strategies that may follow inguinal orchiectomy in clinical stage I seminoma. However, little is known about the outcome of patients who experience a relapse after such treatment. Patients and M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12e87a4769b8d9fb8ed38f433d1d341
https://doi.org/10.5167/uzh-130814
https://doi.org/10.5167/uzh-130814
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eric Pujade-Lauraine, Béatrice Horard, Jérôme Meunier, Jérôme Alexandre, Raymonde Maraval-Gaget, Michel Fabbro, Claire Falandry, Eric Legouffe, Eric Gilson, Gilles Freyer, Valérie Delecroix, Marie-Noëlle Certain, Amandine Bruyas, J. Cretin
Publikováno v:
Aging (Albany NY)
Aging
Aging, Impact Journals, 2015, 7 (12), pp.1066-76. ⟨10.18632/aging.100840⟩
Aging (Albany NY), 2015, 7 (12), pp.1066-76. ⟨10.18632/aging.100840⟩
Aging, 2015, 7 (12), pp.1066-76. ⟨10.18632/aging.100840⟩
Aging
Aging, Impact Journals, 2015, 7 (12), pp.1066-76. ⟨10.18632/aging.100840⟩
Aging (Albany NY), 2015, 7 (12), pp.1066-76. ⟨10.18632/aging.100840⟩
Aging, 2015, 7 (12), pp.1066-76. ⟨10.18632/aging.100840⟩
International audience; PURPOSE: Age induces a progressive decline in functional reserve and impacts cancer treatments. Telomere attrition leads to tissue senescence. We tested the hypothesis that telomere length (TL) could predict patient vulnerabil
Publikováno v:
Respiration. 66:269-272
We describe the case of a 56-year-old man with severe muscle weakness due to heavy hypokalemia (serum potassium 1.44 mmol/l) associated with inappropriate kaliuria and alkalemia. Subsequent investigation revealed the presence of ectopic ACTH hypersec
Autor:
Dominik Berthold, Fernanda G. Herrera
Publikováno v:
Journal of Clinical Oncology, vol. 30, no. 16, pp. 2021; author reply 2022
Autor:
Anna Kalogera-Fountzila, Christos Papadimitriou, Epaminontas Samantas, Dimitris Bafaloukos, E. Briasoulis, Maria Karina, Urania Dafni, Nikos Maniadakis, George Fountzilas, H. P. Kalofonos, Meletios A. Dimopoulos, Angelos Koutras, Gerassimos Aravantinos, P. Kosmidis, D.V. Skarlos, D.G. Pectasides, F. Matsiakou, Helen Gogas, Pavlos Papakostas, C. Christodoulou
BACKGROUND: Effective anthracycline-free combinations need to be evaluated in metastatic breast cancer (MBC), due to the increased number of patients treated with anthracycline-based adjuvant chemotherapy. PATIENTS AND METHODS: Patients with MBC were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c2a1a83506f42d7629b1fc0a96f5a1
http://olympias.lib.uoi.gr/jspui/handle/123456789/24248
http://olympias.lib.uoi.gr/jspui/handle/123456789/24248
Publikováno v:
German Medical Science : GMS e-journal
GMS German Medical Science, Vol 1, p Doc03 (2003)
German Medical Science; VOL: 1; DOC03 /20030701/
GMS German Medical Science, Vol 1, p Doc03 (2003)
German Medical Science; VOL: 1; DOC03 /20030701/
We report of a 34-year old man with second intracranial relapse of a suprasellar germinoma. Despite of extensive pretreatment with radiation and conventional chemotherapy relapse occurred and was treated with sequential high-dose chemotherapy followe